Inhibitory Effects of Vegetable Juices on CYP3A4 Activity in Recombinant CYP3A4 and LS180 Cells

被引:6
|
作者
Tsujimoto, Masayuki [1 ]
Uchida, Tomoe [1 ]
Kozakai, Hiroyuki [1 ]
Yamamoto, Saori [1 ]
Minegaki, Tetsuya [1 ]
Nishiguchi, Kohshi [1 ]
机构
[1] Kyoto Pharmaceut Univ, Fac Pharmaceut Sci, Dept Clin Pharm, Yamashina Ku, Misasagi Nakauchi Cho 5, Kyoto 6078414, Japan
关键词
vegetable juice; CYP3A4; inhibition; drug-beverage interaction; GRAPEFRUIT JUICE; FLAVONOIDS; NISOLDIPINE;
D O I
10.1248/bpb.b16-00263
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It is thought that eating habits induces individual variation in intestinal absorption and metabolism of drugs. The objective of this research was to clarify the influence of vegetables juices on CYP3A4 activity, which is an important enzyme in intestine. Five vegetables juices (VJ-o, Kagome Original (R); VJ-g, Kagome 30 kinds of vegetables and fruits (R); VJ-p, Kagome Purple vegetables (R); VJ-r, Kagome Sweet Tomato (R); and VJ-y, Kagome Fruity Salada (R); KAGOME Co., Ltd., Aichi, Japan) were centrifuged (1630xg, 10min) and filtered using filter paper and 0.45-mu m membrane filters. In this study, recombinant CYP3A4 and L5180 cells were used for the evaluation of CYP3A4 activity. The metabolisms to 6 beta-hydroxytestosterone by recombinant CYP3A4 were significantly inhibited by VJ-o, VJ-g, and VJ-y in a preincubation time-dependent manner, and CYP3A4 activity in L5180 cells were significantly inhibited by VJ-o and VJ-y. These results show that the difference in ingestion volume of vegetable juices and vegetables might partially induce individual difference in intestinal drug metabolism.
引用
收藏
页码:1482 / 1487
页数:6
相关论文
共 50 条
  • [1] Inhibitory Effects of Juices Prepared from Individual Vegetables on CYP3A4 Activity in Recombinant CYP3A4 and LS180 Cells
    Tsujimoto, Masayuki
    Agawa, Chie
    Ueda, Shinya
    Yamane, Takayoshi
    Kitayama, Haruna
    Terao, Aya
    Fukuda, Tomoya
    Minegaki, Tetsuya
    Nishiguchi, Kohshi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2017, 40 (09) : 1561 - 1565
  • [2] Characterization of the human colon carcinoma cell line LS180 - Effects of herbal products on induction of CYP3A4
    Brandin, H
    Viitanen, E
    Myrberg, O
    DRUG METABOLISM REVIEWS, 2005, 37 : 28 - 29
  • [3] Role of CYP3A4 in kinase inhibitor metabolism and assessment of CYP3A4 activity
    Mikus, Gerd
    Foerster, Kathrin Isabelle
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S1592 - S1599
  • [4] CYP3A4 variant alleles in white individuals with low CYP3A4 enzyme activity
    García-Martín, E
    Martínez, C
    Pizarro, RM
    García-Gamito, FJ
    Gullsten, H
    Raunio, H
    Agúndez, JAG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (03) : 196 - 204
  • [5] Effects of metronidazole on hepatic CYP3A4 activity
    Haas, CE
    Kaufman, DC
    DiCenzo, RC
    PHARMACOTHERAPY, 2001, 21 (10): : 1192 - 1195
  • [6] Rapid and drastic induction of CYP3A4 mRNA expression via vitamin D receptor in human intestinal LS180 cells
    Fukumori, Shiro
    Murata, Toshiya
    Taguchi, Masato
    Hashimoto, Yukiya
    DRUG METABOLISM AND PHARMACOKINETICS, 2007, 22 (05) : 377 - 381
  • [7] Omeprazole Induces CYP3A4 mRNA Expression but Not CYP3A4 Protein Expression in HepaRG Cells
    Fujita, Yuto
    Miyake, Takahito
    Shao, Xinyan
    Aoki, Yuto
    Hasegawa, Emi
    Doi, Masao
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2024, 47 (06) : 1218 - 1223
  • [8] Pioglitazone: Effect on CYP3A4 activity
    Nowak, SN
    Edwards, DJ
    Clarke, A
    Anderson, GD
    Jaber, LA
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (12): : 1299 - 1302
  • [9] Effects of CYP3A4 inducers with and without CYP3A4 inhibitors on the pharmacokinetics of maraviroc in healthy volunteers
    Abel, Samantha
    Jenkins, Timothy M.
    Whitlock, Lyndsey A.
    Ridgway, Caroline E.
    Muirhead, Gary J.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 65 : 38 - 46
  • [10] Expression of CYP3A4 mRNA is correlated with CYP3A4 protein level and metabolic activity in human liver
    Watanabe, M
    Kumai, T
    Matsumoto, N
    Tanaka, M
    Suzuki, S
    Satoh, T
    Kobayashi, S
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 (04) : 459 - 462